Published online Oct 7, 2026. doi: 10.3748/wjg.120885
Revised: May 3, 2026
Accepted: June 23, 2026
Published online: October 7, 2026
Processing time: 174 Days and 23.5 Hours
Ulcerative colitis (UC) is associated with excessive endoplasmic reticulum stress (ERS) and gut microbiota dysbiosis. Portulaca oleracea L. (P. oleracea L.), as a food-as-medicine, has demonstrated potential in alleviating colitis symptoms, en
To explore how P. oleracea L.-derived exosome-like nanoparticles (PELNs) alle
In this study, PELNs were isolated and characterized. Colitis was induced by dextran sulfate sodium and microbiota-transplanted mouse models, followed by relevant drug intervention period. Mechanistic investigations were to examine inflammatory factors, oxidative stress and ERS. Fecal samples collection for gut microbiota and metabolite was analyzed.
This study demonstrated that PELNs intervention alleviated colitis through the modulation of the intestinal microbial community and its associated metabolites, thereby reducing ERS by inhibiting the PERK-eIF2α-ATF4 signaling pathway, reducing inflammatory cytokines, and restoring tight junctions in intestinal epithelial cells.
PELNs ameliorate UC by modulating gut microbiota and metabolites, reducing ERS. These findings highlight PELNs as a novel, food-derived, colon-targeted the
Core Tip: The role of Portulaca oleracea L. (P. oleracea L.) in modulating endoplasmic reticulum stress, gut microbiota and metabolites remained unclear. To investigate this, we prepared exosome-like nanoparticles derived from P. oleracea L. and modeled colitis induced by dextran sulfate sodium and microbiota-transplanted mouse. We found that P. oleracea L.-derived exosome-like nanoparticles (PELNs) intervention alleviated colitis through the modulation of the intestinal microbial community and metabolites. PELNs as a novel, food-derived, colon-targeted therapeutic, offering a promising approach for ulcerative colitis treatment.